The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
The acquisition centers on ImCheck’s lead Phase I/II program, ICT01, a first-in-class monoclonal antibody targeting BTN3A
The submissions are supported by data from the Phase 3 KEYNOTE-905 trial
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Expanding US operations to address the increased demand for API development and manufacturing
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
Lutavit A/D3 1000/200 NXT provides a combination of vitamin A and vitamin D3 in one formulation
The new plant will manufacture high-quality Type I borosilicate glass tubing
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
Subscribe To Our Newsletter & Stay Updated
